Trial Profile
Pilot study to assess physical exercise intervention in neoadjuvant treatment with nab-paclitaxel in patients with triple negative breast cancer.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Aug 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer; Early breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
- Acronyms OncoExer
- 16 Aug 2017 New trial record